Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter, Randomized Double-Blind Comparator Trial of the Safety and Sperm and Gonadotropin Suppression Resulting from Combined Use of Nestorone Gel (0, 8 or 12 mg NES) and Testosterone Gel (10g) Compared with Testosterone Gel in Normal Men (Protocol CCN007) (Short Title: NES-2).

Next Previous
Search
Trial Profile

A Multicenter, Randomized Double-Blind Comparator Trial of the Safety and Sperm and Gonadotropin Suppression Resulting from Combined Use of Nestorone Gel (0, 8 or 12 mg NES) and Testosterone Gel (10g) Compared with Testosterone Gel in Normal Men (Protocol CCN007) (Short Title: NES-2).

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 09 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Elcometrine (Primary) ; Testosterone (Primary)
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Acronyms NES-2

    • Most Recent Events

    • 26 Jun 2012 Status changed from active, no longer recruiting to completed.
    • 13 Feb 2011 Actual Initiation Date (1 May 2009 ) added ss reported by ClinicalTrials.gov.
    • 13 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top